Favorable impact of PD1/PD-L1 antagonists on bone remodeling: an exploratory prospective clinical study and ex vivo validation.
Gassner T, Chittilappilly C, Pirich T, Neuditschko B, Hackner K, Lind J, Aksoy O, Graichen U, Klee S, Herzog F, Wiesner C, Errhalt P, Pecherstorfer M, Podar K, Vallet S.
Gassner T, et al. Among authors: lind j.
J Immunother Cancer. 2024 May 3;12(5):e008669. doi: 10.1136/jitc-2023-008669.
J Immunother Cancer. 2024.
PMID: 38702145
Free PMC article.